Search Results
Results found for "chronic pain"
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
pain following repeated surgeries for a pilonidal cyst. pain research at Hopkins and later an MD-PhD at Mount Sinai. pain after three weeks, an effect rarely observed. Venetia Zachariou's lab to study the effects of chronic pain and addiction/withdrawal on the mesocorticolimbic pain and affective comorbidities.
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
Pradhan returns to often: that organisms in chronic pain are fundamentally different biological systems been her scientific focus for nearly two decades, through failed clinical trials in depression and pain pain, and their comorbid emotional states. After failed trials in depression and pain, Dr. pain — and the kappa link 22:22 CGRP, PACAP, and why GPCR drug discovery is not out of runway 28:54
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
“We’re enhancing the powerful pain-relieving effects of opioids while limiting respiratory depression He is particularly excited by the novel application of PAMs in chronic and neuropathic pain models , Discovering breakthrough results in neuroma pain models via a spontaneous collaboration. pain and opioid use disorder. pain.
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics breakthrough GPCR research career The inside story behind founding Blue Therapeutics and targeting supraspinal pain Woolf at Boston Children’s Hospital and Harvard Medical School, where he deepened his understanding of pain Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics , a biotech startup focused on targeting supraspinal GPCRs for chronic pain.
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. research focuses on investigating GPCR signaling and trafficking in the context of inflammation and chronic pain. Next Steps Badr will continue focusing his research on GPCRs involved in pain and inflammation during Badr shared his passion for GPCR signalling and regulation, specifically in the context of pain and inflammation
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
studies encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain and addiction.
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
pain in another, and functions as a mitogen in cancer. the dorsal horn lights up with phospho-ERK in response to opioid, routing through RSK1/2 to stronger pain With a non-selective HSP90 inhibitor given systemically, the brain effect dominates and pain relief is a six-hour feeding window for seven days increased morphine's antinociceptive efficacy in multiple pain The paper is published in Pain , and the translational path is unusually short — you don't need a ten-year
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
studies encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain and addiction.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
studies encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain and addiction.
- Dr. Bruno Giros | Dr. GPCR Ecosystem
At McGill, his laboratory has two main axes of research: 1) Studying interindividual vulnerability to chronic stress and depression and; 2) Understanding the role of phenotypically defined subpopulations
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
at the University of Bonn, Germany, working initially on the role of prostaglandin receptor EP4 in chronic
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
characterized the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fibrosis in acute and chronic
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
synaptic transmission in brain circuits involved in reinforcement learning, with a particular focus on how chronic to ask whether activating mGlu2 in specific corticostriatal circuits can reverse the habit bias that chronic Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
Each of the three RAMPs can pair with a given receptor to produce a distinct complex - different ligand triggers migraine-like headache in susceptible individuals, and drugs targeting that pathway can abolish chronic The scientists who persist, in her framing, are not the ones who feel less pain from those setbacks, She has gained experience from working in academia and at GSK as an industrial trainee.
- Kathryn Livingston: Allosteric Opioid Modulators and Receptor Signaling Beyond the Membrane | Dr. GPCR Ecosystem
receptors under Traynor, characterizing their selectivity, binding mechanisms, and effects on acute and chronic The therapeutic logic is that decoupling from the orthosteric site might preserve pain relief while altering We enhance your endogenous tone, we cause pain relief, maybe we mitigate some of these side effects."
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
If the right ligand could engage G-protein signaling while sparing β-arrestin, pain relief might finally data can still predict FDA pharmacovigilance outcomes, and where iPSC-derived somatic systems actually pay framework, the ligands that permit recycling are the ones that produce less tolerance, whether acute or chronic characterization of the pharmacological properties of cannabinoids in conjunction with terpenes for pain
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
Ian Chronis on the Dr. Ian Chronis In this episode, we welcome Dr. Ian Chronis, a recent Ph.D. graduate preparing to begin his postdoctoral work at the University of Michigan About Ian Chronis I recently finished my PhD in the lab of Dr. Ian Chronis on the web LinkedIn Unlock the Full Dr.
- Affiliate Policy | Dr. GPCR Ecosystem
GPCR to gain access to the Affiliate Program. Commissions are paid on qualifying sales made through the affiliate's unique links. Commissions are not paid on sales that are canceled. GPCR pays affiliates via a PayPal account, provided to us when a member joins. Paid Search Dr. GPCR maintains a strict policy on paid search activity.
- Dr. GPCR Team | Dr. GPCR Ecosystem
conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the
- Dr. Shivani Sachdev | Dr. GPCR Ecosystem
conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain
- Dr. Mark Connor | Dr. GPCR Ecosystem
neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
Classified GPCR News Let’s dive into the Classified GPCR News from February 10th to 16th, 2025 Industry News Pain administration in spinal cord injury GPR37L1 identifies spinal cord astrocytes and protects neuropathic pain Neuroregeneration , EPSC , GLT-1 , GPR37L1 , SPM , astrocytes , maresin 1 , microglia , nerve injury , neuropathic pain
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential GPCRs in Neuroscience Cortical astrocyte activation triggers meningeal nociception and migraine-like pain
- InĂŞs Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem
passion, I recently started a postdoctoral fellowship to study the role of GPCRs in the mechanisms of pain
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Mike's lab has two main areas of interest: 1) alternative polyadenylation as a targetable driver of pancreatic He shared that his interest in science originated from a young age and his desire to gain more knowledge However, he decided to undertake another postdoc to gain more experience and confidence. The conversation ended with Yamina expressing interest in learning more about Mike's two main research
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
Klein's lab where she helped to investigate the role of various ATP-sensitive potassium channels in pain
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
. 🌟 By teaching with us, you gain: ✔ Premium Membership for you and your team for one year (no credit Course details – title, format (short talk / mini-course / series), audience, main objectives, expected
- Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem
of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
His main research group centers on the function, structure, and regulation of G protein-coupled receptors





























